1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Start date pushed from Sep 1, 2026 to Oct 8, 2026
Shanghai Jiao Tong University School of MedicineNot applicable NCT07645677 Registry history of NCT07645677 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07876544 Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney… | Phase 4 | Recruiting |
| 2026-10-02 | NCT07854145 Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery | Not Yet Recruiting | |
| 2026-09-29 | NCT07848152 Active Surveillance and Safety/Efficacy Evaluation of Innovative Devices for Structural… | Recruiting | |
| 2026-09-28 | NCT07844941 Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With… | Recruiting | |
| 2026-09-22 | NCT07833228 A Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of… | Not Yet Recruiting |
| Early Phase 1 | 9 | |
| Phase 1 | 5 | |
| Phase 1/2 | 3 | |
| Phase 2 | 16 | |
| Phase 2/3 | 3 | |
| Phase 3 | 8 | |
| Phase 4 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07876544 | Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney… | Hypertension | Recruiting | 2026-10-15 |
| NCT06930157 | Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent… | Low-risk Colorectal Adenoma | Recruiting | 2026-01-28 |
| NCT05874570 | Doxycycline for Helicobacter Pylori Rescue Treatment | Helicobacter Pylori Infection | Recruiting | 2024-12-30 |
| NCT04111419 | Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With… | Atrial Fibrillation | Active, Not Recruiting | 2025-08-13 |
| NCT05843292 | Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy… | Triple-negative Breast Cancer | Not Yet Recruiting | 2023-06-06 |
| Phase 3 | ||||
| NCT07797218 | Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Recruiting | 2026-09-01 |
| NCT06705062 | Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in… | Allogeneic Hematopoietic Cell Transplant | Recruiting | 2026-03-17 |
| NCT05991908 | Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating… | Acute Myeloid Leukemia | Recruiting | 2025-02-18 |
| NCT06829472 | Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of… | Toxicities | Recruiting | 2025-02-17 |
| NCT07761702 | Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML | AML (Acute Myelogenous Leukemia) | Not Yet Recruiting | 2026-08-12 |
| NCT03932136 | Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) | Clinical High Risk Syndrome of Psychosis | Active, Not Recruiting | 2026-06-03 |
| NCT02455141 | Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast… | Breast Neoplasm | Active, Not Recruiting | 2025-07-11 |
| NCT07060391 | A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the… | Alzheimer's Disease | Not Yet Recruiting | 2025-07-11 |
| Phase 2/3 | ||||
| NCT03258320 | A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus… | Prostate Cancer Patients | Recruiting | 2026-01-12 |
| NCT06607419 | Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed… | B-Cell Lymphoblastic Leukemia | Recruiting | 2024-09-23 |
| NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | Oral Squamous Cell Carcinoma | Recruiting | 2023-11-22 |
| Phase 2 | ||||
| NCT07303803 | A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis… | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Recruiting | 2026-06-03 |
| NCT07335081 | ctDNA in HER2+ EBC Neoadjuvant Treatment | Breast Cancer | Recruiting | 2026-03-24 |
| NCT05436561 | Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies | Disease-free Survival | Recruiting | 2026-03-17 |
| NCT07393425 | Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer | HER2 + Breast Cancer | Recruiting | 2026-02-06 |
| NCT07371208 | Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination… | Breast Cancer | Recruiting | 2026-01-27 |
| NCT06500208 | Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC | Breast Cancer | Recruiting | 2025-06-26 |
| NCT05870995 | Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory… | Refractory Leukemia | Recruiting | 2025-02-18 |
| NCT05881265 | Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute… | APL | Recruiting | 2025-02-18 |
| NCT05891561 | Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early… | Breast Cancer | Recruiting | 2024-11-27 |
Breast Cancer (14) · Diabetes (11) · Leukemia (9) · Acute Myeloid Leukemia (AML) (7) · Hypertension (7) · Head & Neck Cancer (5) · Heart Disease (5) · Type 2 Diabetes (4) · Obesity (3) · Acute Lymphoblastic Leukemia (ALL) (2)